Inventor

SCHAUS JOHN MEHNERT

US22 patents

⚠️ This page may combine multiple inventors who share the name “SCHAUS JOHN MEHNERT”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SCHAUS JOHN MEHNERT

LILLY CO ELI

5-HT1F agonists

5-Substituted-3-(1,2,3,6-tetrahydropyridin-4-yl)-and 3-(piperidin-4-yl)-1H-indoles: new 5-HT1F agonists

N-(2-Arylethyl) benzylamines as antagonists of the 5-HT6 receptor

5-substituted-3-(1,2,3,6-tetrahydropyridin-4-yl)-and 3-(piperidin-4-yl)-1h-indoles: 5-HT1F agonists

Substituted heteroaromatic 5-HT1F agonists

5-HT1F agonists

N-(2-arylethyl)benzylamines as antagonists of the 5-HT6 receptor

Non-imidazole aryl alkylamines compounds as histamine H3 receptor antagonists, preparation and therapeutic uses

3,4-dihydroisoquinolin-2(1H)-yl compounds

5-HT1f agonist

Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders

Piperazine substituted aryl benzodiazepines

1,5-diphenyl-3-pyridinylamino-1,5-dihydropyrrolidin-2-one as CB1 receptor modulator

Benzenesulfonic acid indol-5-yl esters as antagonists of the 5ht6 receptor

5-HT1F agonists intermediates

Nitropyridine compound

1-(2-m-methanesulfonamidophenylethyl)-4-(m-trifluoromethylphenyl) piperazine and pharmaceutically acceptable salts and solvents thereof

Indole derivatives and their use as 5-HT1F agonists

SCHAUS JOHN MEHNERT

1,5-Diphenyl-pyrrolidin-2-one compounds as CB-1 ligands

ARNOLD MACKLIN BRIAN

Inhibitors of diacylglycerol acyltransferase

COFFEY DAVID SCOTT

1, 5-diphenyl-3-benzylamino-1, 5-dihydropyrrolidin-2-one as CB1 receptor modulators

BADESCU VALENTINA O

2-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-3-phenyl pyrazines as 5-HT7 receptor antagonists